Mesalamine Clinical Trials
8 recruitingDrug
Phase 28Phase 32
Showing 1–8 of 8 trials
Recruiting
Phase 2
Pentoxifylline in Patients With Ulcerative Colitis
Inflammatory Bowel Diseases
Ihab Elsayed Hassan60 enrolled1 locationNCT07349472
Recruiting
Phase 2Phase 3
Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Inflammatory Bowel Diseases
Mostafa Bahaa50 enrolled1 locationNCT05986136
Recruiting
Phase 2
Rupatadine in Patients With Ulcerative Colitis
Ulcerative Colitis
Alexandria University60 enrolled1 locationNCT07064707
Recruiting
Phase 2
Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)
Advanced MelanomaDiarrheaImmune-related Adverse Event+1 more
AHS Cancer Control Alberta20 enrolled1 locationNCT05663775
Recruiting
Phase 2
Nitazoxanide in Patients With Ulcerative Colitis
Ulcerative Colitis
Alexandria University70 enrolled1 locationNCT06993974
Recruiting
Phase 2Phase 3
Fenofibrate in Ulcerative Colitis
Inflammatory Bowel Diseases
Tanta University60 enrolled1 locationNCT05753267
Recruiting
Phase 2
Beneficial Effect of Silymarin in Ulcerative Colitis
Ulcerative Colitis
Tanta University44 enrolled2 locationsNCT06213857
Recruiting
Phase 2
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
Colon CancerColon NeoplasmLynch Syndrome
Ann-Sofie Backman150 enrolled8 locationsNCT04920149